News and Media
;
New “window-of-opportunity” clinical trials explore cutting-edge treatments for cancers of the liver, head and neck
Two new studies join the Ontario Institute for Cancer Research (OICR) portfolio of Window-of-Opportunity (WOO) Network clinical trials. April 18, 2024, TORONTO – A new round of clinical trials supported by the Ontario Institute for Cancer Research (OICR) will harness a unique opportunity to test some of the newest treatment strategies for a range of […]
Read the story
May 03, 2024
A message from the President and Scientific Director on the passing of Andrea Redway
Apr 22, 2024
How two cancers make themselves harder to treat by suppressing the immune system
Apr 17, 2024
‘Smart people’ working to make a difference: Co-op student reflects on OICR conference
Apr 16, 2024
Student-developed machine learning model can predict how medicines treat different tumours
Apr 03, 2024
Ontario cancer community comes together at OICR Translational Research Conference
Apr 02, 2024
FDA approves first cell therapy in landmark achievement for personalized medicine
Mar 25, 2024
OICR-supported cancer therapeutics company Fusion Pharmaceuticals acquired by AstraZeneca for $2 billion
Mar 22, 2024
How the Ontario Cancer Research Ethics Board protects participants while streamlining research in the province
Mar 22, 2024
Ask a cancer researcher: Is there a blood test for cancer?
Mar 06, 2024
How AI can help diagnose cancers that are otherwise hard to spot
Feb 28, 2024
“Dream team” science helps move Ontario ahead of the curve on hard-to-treat cancers
Feb 27, 2024
Using AI to connect cancer patients with cutting-edge clinical trials
Looking Ahead
Receive the latest news, event invites, funding opportunities and more from the Ontario Institute for Cancer Research.